Viking Therapeutics Inc. (VKTX)

The total Gamma Exposure (GEX) for VKTX across all expirations is 105,770.16 shares per 1% move, with 151,700.46 from calls and 45,930.3 from puts. The put-call GEX ratio of 0.30 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Jan 16, 26 expiration with 30,967.38 net GEX, which may act as a magnet point for price action. Near-term exposure for Sep 5, 25 suggests potential support from positive gamma hedging flows.